• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: atezolzumab

  • PD-L1 Immunotherapy Delayed Triple Negative Breast Cancer Progression 0
    • in AJO · Audio · Oncology
    • — 31 Oct, 2018

    PD-L1 Immunotherapy Delayed Triple Negative Breast Cancer Progression

    MUNICH— Immunotherapy with the anti programmed death ligand 1 (PD-L1) checkpoint inhibitor atezolizumab in combination with nab-paclitaxel chemotherapy prolonged progression-free survival (PFS) among patients with metastatic triple-negative breast cancer in the randomized phase three IMpassion130 trial reported at the 2018 …

    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: atezolzumab

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.